A
$ Value
$0
Shares
1,220
Price
$0
Filed
Jan 23
Insider
Name
Tracey Kevin
Title
—
CIK
0002107022
Roles
Director
Transaction Details
Transaction Date
2026-01-21
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,220
Footnotes
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. | In connection with Kevin Tracey's appointment to the Board of Directors on January 21, 2026, he was awarded restricted stock units in accordance with the Non-Employee Director Compensation Program. Each award becomes fully vested on the one-year anniversary of the grant date. | Not applicable as restricted stock units do not have an expiration date.
Filing Info
Tracey Kevin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-21 | UTHR | A | $0 |
Other Insiders at UTHR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ROTHBLATT MARTINE A
Chairperson & CEO
|
— | $193.8M | 2026-04-22 |
| KURZWEIL RAY | — | $2.4M | 2026-03-04 |
| PATUSKY CHRISTOPHER | — | $579K | 2026-04-17 |
|
MAHON PAUL A
EVP & GENERAL COUNSEL
|
— | $25.9M | 2026-04-16 |
| CAUSEY CHRISTOPHER | — | $1.3M | 2026-03-30 |
| Thompson Tommy G | — | $2.1M | 2026-03-26 |
| Olian Judy D. | — | $417K | 2026-03-23 |
|
EDGEMOND JAMES
CFO AND TREASURER
|
— | $50.8M | 2026-04-20 |
|
BENKOWITZ MICHAEL
PRESIDENT AND COO
|
— | $60.0M | 2026-03-15 |
| MALCOLM JAN | — | $97K | 2026-03-17 |